Green Fresh Biotechnology Co

Green Fresh Biotechnology Co Current Assets

The Current Assets of Green Fresh Biotechnology Co (1084.HK) as of Nov 5, 2026 is 976.82 M CNY. In the previous year, Current Assets was 924.69 M CNY — a change of 5.64% (higher).

Current Assets

976.82 MCNY

YoY

5.64%

Last updated:

Current Assets of Green Fresh Biotechnology Co is 2025 976.82 M CNY. Current Assets of Green Fresh Biotechnology Co was 2024 924.69 M CNY. It decreases by 5.64% higher compared to the previous year.

The Green Fresh Biotechnology Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
397.60 M CNY
Jan 1, 2019
661.37 M CNY
Jan 1, 2020
805.66 M CNY
Jan 1, 2021
889.72 M CNY
Jan 1, 2022
1.34 B CNY
Jan 1, 2023
891.54 M CNY
Jan 1, 2024
924.69 M CNY
Jan 1, 2025
976.82 M CNY
The Green Fresh Biotechnology Co Current Assets history
YEARCurrent AssetsYoY
976.82 MCNY+5.64%
924.69 MCNY+3.72%
891.54 MCNY-33.37%
1.34 BCNY+50.39%
889.72 MCNY+10.43%
805.66 MCNY+21.82%
661.37 MCNY+66.34%
397.60 MCNY+39.29%
285.44 MCNY+9.83%
259.90 MCNY+46.15%
177.84 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Green Fresh Biotechnology Co Stock analysis

What does Green Fresh Biotechnology Co do? Green Future Food Hydrocolloid Marine Science Co., Ltd. generates revenue through the production and sale of hydrocolloid products for food manufacturing. The company operates across five segments: agar-agar for jelly, carrageenan for confectionery and snacks, konjac products, blended products for meat, and milk powder sales. Its primary buyers include food manufacturers and confectionery companies seeking hydrocolloid ingredients for their products. The firm's business model relies on direct sales of these specialized food additives to industrial clients in the food processing sector. The agar-agar segment focuses on jelly production, while carrageenan targets confectionery and snack manufacturers. Konjac products serve as a key ingredient in various food applications, and blended products are tailored for meat processing. The milk powder segment provides an additional revenue stream through dairy product sales. All segments operate under the company's investment holding structure, with no external partners or third-party services mentioned in the business description. Revenue is derived from the sale of hydrocolloid-based food additives across multiple food industry applications. The company's product portfolio includes agar-agar, carrageenan, konjac, blended compounds, and milk powder, each serving distinct food manufacturing needs. Industrial clients purchase these products to enhance texture, stability, and quality in their final food products. Green Fresh Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Green Fresh Biotechnology Co stock

Current Assets of Green Fresh Biotechnology Co is 976.82 M CNY in 2025.

Current Assets of Green Fresh Biotechnology Co changed from 924.69 M CNY to 976.82 M CNY, representing a 5.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Green Fresh Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Green Fresh Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Green Fresh Biotechnology Co

All Key Metrics — Green Fresh Biotechnology Co